Fisher & Paykel Healthcare
| Company type | Public |
|---|---|
| NZX: FPH | |
| ISIN | NZFAPE0001S2 |
| Industry | Healthcare devices |
| Founded | 1934; 91 years ago |
| Founder | Maurice Paykel & Sir Woolf Fisher |
| Headquarters | , New Zealand |
Key people | Lewis Gradon, Managing Director and CEO |
| Products | CPAP, Respiratory Humidifiers, Neonatal Care |
| Revenue | NZ$1263 million (2020) |
| NZ$379 million (2020) | |
| NZ$287 million (2020) | |
Number of employees | 5,081(2020) |
| Website | www |
Fisher & Paykel Healthcare Corporation Limited (FPH) is a manufacturer, designer and marketer of products and systems for use in respiratory care, acute care, and the treatment of obstructive sleep apnea. Based in New Zealand, their products and systems are sold in around 120 countries worldwide. FPH is primarily an exporting company, with just 1 percent of revenue coming from New Zealand sales.